Sign in

Leo Scheller

@leoscheller.bsky.social
1.2K followers 700 following 20 posts

Immunotherapy, CAR-T, Protein Design, Synthetic biology, Cell Signaling. Head of Research Group | Structural Biochemistry | LIT Leibniz Institute for Immunotherapy lit.eu/our-scientists/dr-leo-schell…

PostsRepliesMedia
Reposted by Leo Scheller
Nature Chemical Biology @natchembio.nature.com · 25/09/2026
Our October issue is live! www.nature.com/nchembio/vol... Inspired by the phases of the moon, the cover artwork uses light and darkness to depict pharmacological control of chimeric antigen receptor (CAR) T cells
Inspired by the phases of the moon, the cover artwork uses light and darkness to depict pharmacological control of chimeric antigen receptor (CAR) T cells. Introduction of a drug reversibly disengages the CAR extracellular domain from tumor cells
031
Leo Scheller @leoscheller.bsky.social · 29/09/2026
Beautiful! Grateful for having coauthors with additional talents to science. Congratulations on making the cover, amazing job 🙌
001
Reposted by Leo Scheller
Khmelinskaia Lab @akhmelinlab.bsky.social · 05/07/2026
De novo designed oligomers that respond to copper, small molecules, and phosphorylation... Using a single design strategy? 🧬⚙️ 🎉 Excited to share our new bioRxiv preprint—a collaboration between the Khmelinskaia, Correia, Schoeder and a Tinnefeld labs! www.biorxiv.org/content/10.6...
biorxiv.org
A generalizable interface-seeded framework for de novo design of functional oligomers
Protein oligomers are ubiquitous in biological systems and essential for function. However, the de novo design of oligomers that controllably assemble in response to exogenous stimuli remains challeng...
2259
Reposted by Leo Scheller
Nicholas Southern @neuroscinikolai.bsky.social · 05/07/2026
New preprint! We used protein domain insertion to tighten the editing window of the TadA8e adenine base editor. Bulky domain insertions concentrated editing around position A5, maintained robust on-target activity, and reduced Cas-independent off-target editing. 🧬 doi.org/10.64898/202...
biorxiv.org
Domain Insertion Improves the Precision of a CRISPR Adenine Base Editor
Adenine base editors (ABEs) enable efficient A:T to G:C conversion, but their broad activity windows frequently cause unintended bystander edits. We hypothesized that insertion of a bulky, inert prote...
2126
Reposted by Leo Scheller
Martin Pacesa @martinpacesa.bsky.social · 15/06/2026
Our lab website is finally online! pacesalab.com You can find information about our research, publications, and on-going developments in the lab.
1508
Reposted by Leo Scheller
Nature @nature.com · 18/04/2026
A system of protein binders directs energy-generating organelles to targeted cells, potentially improving ways to treat mitochondrial dysfunction go.nature.com/42bk2wX
go.nature.com
Therapeutic mitochondria transplants made more efficient with targeting tool
A system of protein binders directs energy-generating organelles to targeted cells, potentially improving ways to treat mitochondrial dysfunction.
0479
Reposted by Leo Scheller
UCSF Helen Diller Family Comprehensive Cancer Center @ucsfcancer.bsky.social · 07/04/2026
DROP-CARs: Engineering Reversible, Drug-Controlled CAR T Cell Activity with a Clinically Approved Small Molecule | Wendell Lim @ucsanfrancisco.bsky.social Adam Stevens @upenn.edu via @theaacr.bsky.social url: aacrjournals.org/cancerres/ar...
aacrjournals.org
DROP-CARs: Engineering Reversible, Drug-Controlled CAR T Cell Activity with a Clinically Approved Small Molecule
Abstract. A major limitation in applying chimeric antigen receptor (CAR) T cells to solid tumors is toxicity in healthy tissues caused by a lack of tumor-specific targets. A promising strategy to over...
052
Reposted by Leo Scheller
Nature Chemical Biology @natchembio.nature.com · 24/02/2026
Drug-controlled DROP-CARs enable reversible extracellular control of CAR T cell function via human-derived protein switches that modulate cell-cell interactions and support dual-antigen targeting as well as logic-gated signaling www.nature.com/articles/s41...
nature.com
Drug-controlled CAR T cells through the regulation of cell–cell interactions - Nature Chemical Biology
Drug-controlled DROP-CARs enable reversible extracellular control of CAR T cell function via human-derived protein switches that modulate cell–cell interactions and support dual-antigen targeting as w...
031
Reposted by Leo Scheller
BIOspektrum @claudialudy.bsky.social · 04/03/2026
Manchmal greifen CAR-T-Zellen gesundes Gewebe an und verursachen Nebenwirkungen. Ein internationales Forscherteam hat nun ein System entwickelt, um die Bindung von T-Zellen an andere Zellen durch ein zugelassenes Medikament zu kontrollieren. doi.org/10.1038/s415... Bild: Copyright: Leo Scheller
021
Reposted by Leo Scheller
EMBL-EBI @ebi.embl.org · 16/03/2026
You asked, we listened. Millions of AI-predicted protein complex structures are now available in the #AlphaFold Database. This spans homodimers from 20 of the most studied species, including humans, as well as the World Health Organization’s priority pathogens list. www.ebi.ac.uk/about/news/t...
816087
Reposted by Leo Scheller
Kieran Didi @kdidi.bsky.social · 17/03/2026
📢 We’re launching Proteina-Complexa — and after the Jensen keynote mention, we definitely had to post this thread now ;) Atomistic binder design with generative pretraining + test-time compute, plus large-scale wet-lab validation. Project page: research.nvidia.com/labs/genair/... 🧵 1/n
13716
Reposted by Leo Scheller
German Association for Synthetic Biology (GASB) e.V @gasb-synbio.bsky.social · 11/03/2026
High throughput data are more important than ever💻. On this note, Markus Jeschek from EPFL, shows us how translation initiation can be engineered, utilizing mRNA folding or tRNA interactions to tune protein production📈!
051
Reposted by Leo Scheller
Benjamin Friedrich @friedrich-group.bsky.social · 03/03/2026
Looking for a theory partner for an #HFSP project? #morphogenesis in cells and tissues, #chemotaxis, #cilia? Feel free to reach out! Deadline for letters of intent 26.03.2026. physics-of-life.tu-dresden.de/team/pol-gro...
physics-of-life.tu-dresden.de
PoL – Physics of Life | Team | PoL Groups | Benjamin Friedrich
Physics of Life: Discover new paradigms for understanding life and deepen our knowledge of living biological matter
033
Reposted by Leo Scheller
Informationsdienst Wissenschaft - idw @idw-online.de · 03/03/2026
Wirkstoff-gesteuerte CAR-T-Zellen: Ein neuer Sicherheitsmechanismus für die Krebsimmuntherapie Die chimäre Antigenrezeptor-(CAR)-T-Zelltherapie basiert auf gentechnisch veränderten Immunzellen, die Krebszellen aufspüren und zerstören. Manch... weiterlesen
Schematische Darstellung eines DROP-CAR - Copyright Leo Scheller
032
Reposted by Leo Scheller
Neva Caliskan @caliskanlab.bsky.social · 06/03/2026
We are looking for RNA enthusiasts to join us at the @uniregensburg.bsky.social as a junior group leader! Our university offer excellent infrastructure and collaboration opportunities for ground breaking RNA research. Please RT @jrrnascientists.bsky.social @rnasociety.bsky.social
0119
Leo Scheller @leoscheller.bsky.social · 03/03/2026
The core idea of this project was that we wanted a new CAR safety switch that works with minimally altered human proteins, an approved drug, and by breaking or inhibiting cell-cell contact. After a lot of optimization, this worked pretty well! www.nature.com/articles/s41...
nature.com
Drug-controlled CAR T cells through the regulation of cell–cell interactions - Nature Chemical Biology
Drug-controlled DROP-CARs enable reversible extracellular control of CAR T cell function via human-derived protein switches that modulate cell–cell interactions and support dual-antigen targeting as w...
150
Reposted by Leo Scheller
Amanda Moehring @flybehaviour.bsky.social · 13/02/2026
Ooooh. Cool new paper on origins of life. A simple 45-nucleotide RNA molecule that can perfectly copy itself. www.science.org/doi/10.1126/...
science.org
A small polymerase ribozyme that can synthesize itself and its complementary strand
The emergence of a chemical system capable of self-replication and evolution is a critical event in the origin of life. RNA polymerase ribozymes can replicate RNA, but their large size and structural ...
014358
Reposted by Leo Scheller
Paul & Virginie - Centriole Lab @centriolelab.bsky.social · 10/12/2025
We’re excited to announce the opening of the Geneva Expansion Microscopy Facility (GenExM)! GenExM is a full-service U-ExM platform (U-ExM, Cryo-ExM, iU-ExM), delivering nanoscale imaging. Led by Dr. Olivier Mercey, GenExM welcomes academic & industrial collaborations. 👉 www.unige.ch/genexm/
214235
Reposted by Leo Scheller
Kerstin Göpfrich @kgoepfrich.bsky.social · 09/12/2025
We are recruiting a tenure track professor in the broader area of molecular biology @zmbh.uni-heidelberg.de at Heidelberg University! www.nature.com/naturecareer... Please share and apply!
nature.com
Tenure Track Professorship (W1 with Tenure Track to W3) in “Molecular Biology" (f/m/d) - Heidelberg job with Universität Heidelberg | 12850668
The Center for Molecular Biology of Heidelberg University (ZMBH) and the Faculty of Biosciences invite applications for a   Tenure Track Professors...
06958
Reposted by Leo Scheller
Simon Dürr @handle.invalid · 01/10/2025
Cool work to design phospho-tyrosine binder by the Baker lab. They show it works but success rate is low (<0.1%) and binders are not super strong (>500nM, likely related to cost of desolvating the phosphate) . www.biorxiv.org/content/10.1...
1165
Reposted by Leo Scheller
Adrian Woolfson @adrianwoolfson.bsky.social · 04/10/2025
A computationally-designed ‘random walker’ protein with tiny feet can walk back and forth across a micrometer-long fiber share.google/3gzWosAVOeAh...
share.google
De-novo design of a random protein walker
Molecular machines hold great potential. Design of static monomeric and oligomeric protein structures has advanced tremendously, but few dynamic protein systems have been designed. Here we present the...
031
Reposted by Leo Scheller
Nature @nature.com · 01/09/2025
Nature research paper: One-shot design of functional protein binders with BindCraft go.nature.com/46bhOAv
go.nature.com
One-shot design of functional protein binders with BindCraft - Nature
BindCraft, an open-source, automated pipeline for de novo protein binder design with experimental success rates of 10–100%, leverages AlphaFold2 weights to generate binders with nanomolar affinity without the need for high-throughput screening.
15020
Reposted by Leo Scheller
Martin Pacesa @martinpacesa.bsky.social · 27/08/2025
Exciting to see our protein binder design pipeline BindCraft published in its final form in @Nature ! This has been an amazing collaborative effort with Lennart, Christian, @sokrypton.org, Bruno and many other amazing lab members and collaborators. www.nature.com/articles/s41...
14305109
Reposted by Leo Scheller
Martin Pacesa @martinpacesa.bsky.social · 25/07/2025
I am super excited to announce that I will be starting my lab at the Department of Pharmacology of the University of Zurich in Switzerland next year!
2321839
Leo Scheller @leoscheller.bsky.social · 26/07/2025
Watch out, one of the best in the field! 😀
260
Reposted by Leo Scheller
Martin Pacesa @martinpacesa.bsky.social · 12/07/2025
We (meaning Aswin and Stan www.biorxiv.org/content/10.1...) found this jumbophage protein homologue of PhiKZ_124 that activates Avast5 and we solved a 2.1A cryoEM structure of but we have no idea what it does. Let me know it you got some idea. www.rcsb.org/structure/9RP3
biorxiv.org
Molecular basis for anti-jumbo phage immunity by AVAST Type 5
Jumbo phages protect their genomes from DNA-sensing bacterial defense systems by enclosing them within vesicles and nucleus-like compartments. Very little is known about defense systems specialized to...
0286
Leo Scheller @leoscheller.bsky.social · 08/07/2025
My highest recommendation! Working with Martin is the ideal entry point into protein design.
112
Reposted by Leo Scheller
bioRxiv Synthetic Biology @biorxiv-synthbio.bsky.social · 14/06/2025
Humanized Caffeine-Inducible Systems for Controlling Cellular Functions www.biorxiv.org/content/10.1101/202…
075
Reposted by Leo Scheller
bioRxiv Synthetic Biology @biorxiv-synthbio.bsky.social · 14/06/2025
Caffeine-regulated molecular switches for functional control of CAR T cells in vivo www.biorxiv.org/content/10.1101/202…
072
Reposted by Leo Scheller
Gregor Hagelueken @gha14.bsky.social · 18/05/2025
Happy to share our first foray into the world of AI-based #ProteinDesign. www.biorxiv.org/content/10.1...
biorxiv.org
Development of AI-designed protein binders for detection and targeting of cancer cell surface proteins
Artificial intelligence (AI)-based protein design opens new avenues for the rapid generation of new research tools and therapeutics, but experimental validation lags behind the computational design th...
154
Reposted by Leo Scheller
Chise @sailorrooscout.bsky.social · 16/05/2025
THIS IS HUGE! TWO Phase I HIV vaccine clinical trials have demonstrated that a stepwise mRNA-based vaccination strategy can SUCCESSFULLY activate AND advance immune responses toward producing broadly neutralizing antibodies (bnAbs), a CRITICAL milestone in HIV prevention. Let’s talk about that! 🧪🧵⬇️
3238991139
Reposted by Leo Scheller
Diego del Alamo @delalamo.xyz · 15/05/2025
"Adapting ProteinMPNN for antibody design without retraining" Our several-years-old fix to ProteinMPNN's tendency to make weird antibody CDR sequences is finally preprinted
biorxiv.org
Adapting ProteinMPNN for antibody design without retraining
The neural network ProteinMPNN designs protein sequences capable of folding into predefined tertiary structures and quaternary assemblies. It has become widely used due to its high success rates when ...
14614
Reposted by Leo Scheller
Roger Castells @rcastellsg.bsky.social · 07/05/2025
Hi everyone! I’m a #NewPI just starting my lab and would love to hear your advice on lab management and building the lab culture. Any tips, lessons learned, or resources you’ve found helpful are very welcome! Feel free to reply, message me, or email me at rcastellsg(at)cnio.es thanks a lot!! 🤗
media.tenor.com
a cat is sitting in front of a laptop computer asking for advice
ALT: a cat is sitting in front of a laptop computer asking for advice
183819
Reposted by Leo Scheller
Erik van Nimwegen @erikvannimwegen.bsky.social · 09/05/2025
Here it is! Bonsai. Now there is really no more excuse for using t-SNE/UMAP. Bonsai not only makes cool pictures of your data. It actually rigorously preserves its structure. No tunable parameters. Incredible work by @dhdegroot.bsky.social. I'm so excited about this! www.biorxiv.org/content/10.1...
biorxiv.org
Bonsai: Tree representations for distortion-free visualization and exploratory analysis of single-cell omics data
Single-cell omics methods promise to revolutionize our understanding of gene regulatory processes during cell differentiation, but analysis of such data continues to pose a major challenge. Apart from...
9335108
Reposted by Leo Scheller
Dominik Niopek @dominikniopek.bsky.social · 05/05/2025
www.biorxiv.org/content/10.1...
biorxiv.org
Modular Engineering of Thermo-Responsive Allosteric Proteins
Thermogenetics enables non-invasive spatiotemporal control over protein activity in living cells and tissues, yet its applications have largely been restricted to transcriptional regulation and membra...
0147
Reposted by Leo Scheller
Max Fürst @maxfus.bsky.social · 03/05/2025
If u ever had to depict proteins as schematics in papers, u know the dilemma: how to create a pretty “blob”? If structure ends up big & central, u’ll render it with PyMol et al, but for a truly schematic depiction u want a biorender-style icon, but for YOUR protein. Think I’ve finally found a way.
719246
Reposted by Leo Scheller
ross @rosscloney.bsky.social · 02/05/2025
Programmable protein stabilization with language model-derived peptide guides www.nature.com/articles/s41...
nature.com
Programmable protein stabilization with language model-derived peptide guides - Nature Communications
Dysregulated protein degradation drives diseases like cancer. Here, authors use protein language models to design target-binding peptides, which are subsequently attached to the catalytic domain of th...
121
Reposted by Leo Scheller
Aaron Ring @aaronmring.bsky.social · 29/04/2025
You’ve heard of vibe coding—meet vibe protein design. Click, launch, and watch the binders roll in. That’s what we're unveiling with @ariaxbio.bsky.social today.
2175
Reposted by Leo Scheller
Martin Steinegger 🇺🇦 @martinsteinegger.bsky.social · 27/04/2025
AFESM: a metagenomic guide through the protein structure universe! We clustered 821M structures (AFDB&ESMatlas) into 5.12M groups; revealing biome-specific groups, only 1 new fold even after AlphaFold2 re-prediction & many novel domain combos. 🧵 🌐 afesm.foldseek.com 📄 www.biorxiv.org/content/10.1...
414170
Reposted by Leo Scheller
James Lingford @jameslingford.bsky.social · 28/04/2025
Baker lab PyMOL config 👇
0112
Reposted by Leo Scheller
Miha Modic @paraspeckle.bsky.social · 18/04/2025
Thank you, Lennart! I'm very excited to join the newly founded Carl Zeiss Center for Synthetic Genomics and KIT with your lab nextdoor! Exciting times ahead!
162
Leo Scheller @leoscheller.bsky.social · 13/03/2025
I’m looking for a BTA and a Postdoc to help set up the Structural Biochemistry group at the Leibniz Institute for Immunotherapy (LIT) in Regensburg 😀. We apply synthetic biology and protein design to address key challenges in immunotherapy. lit.eu/work-with-us/ #SynBio #ProteinDesign #Immunotherapy
lit.eu
Work With Us
The LIT welcomes individuals from all life paths and academic backgrounds. If you are passionate about science we could be the perfect home for you.
0104
Reposted by Leo Scheller
Academic Europe @academiceurope.bsky.social · 13/03/2025
Job - Alert 🌱 ‼️ POSTDOCTORAL SCIENTIST (M/F/D) Deadline: 2025-04-06 Location: Germany, Regensburg, Bayern www.academiceurope.com/job/?id=7176 #hiring #Immunotherapy #Postdoc #LIT #syntheticbiology #proteindesign
academiceurope.com
Academic Europe - Postdoctoral scientist (m/f/d)
032
Reposted by Leo Scheller
Brian Naughton @btnaughton.bsky.social · 08/03/2025
new blogpost on protein binder design blog.booleanbiotech.com/protein-bind...
blog.booleanbiotech.com
Boolean Biotech
2184
Reposted by Leo Scheller
Adrian Stefanov @adrian-stefanov.bsky.social · 08/03/2025
Hello bluesky
061
Reposted by Leo Scheller
Martin Pacesa @martinpacesa.bsky.social · 07/03/2025
Hats off to all our american colleagues out there protesting in the streets today, scientific progress is the only way to a better future and no government should stand in the way of that ✊🏼
0244
Reposted by Leo Scheller
René Inckemann @reneinckemann.bsky.social · 05/03/2025
@synbio4allafrica.bsky.social #PlantSynBio education project will enable local students to sequence a native plant species and gain hands-on research and data analysis skills. They’ve secured ~76% of their microgrant. Now they need our help to cross the finish line: experiment.com/projects/exp...
experiment.com
Exploring African biodiversity with an open-source educational program in Plant Synthetic Biology
Much of Africa's plants have not been studied. As a non-profit, SynBio4ALL aims to study plant biodiversity in combination with emerging technology to educate and inspire future African scientists. We...
01411
Leo Scheller @leoscheller.bsky.social · 26/02/2025
I’m happy to share that I will join the LIT in Regensburg (lit.eu) as a Group Leader in Structural Biochemistry in May. We will combine synthetic biology and protein design to develop synthetic receptors and protein therapeutics to improve immunotherapy. Job openings will be available soon!
lit.eu
Leibniz Institute for Immunotherapy
The LIT develops innovative therapies for the treatment of cancer, autoimmunity, and chronic inflammation by reprogramming immune cells.
8265
Reposted by Leo Scheller
Kevin K. Yang 楊凱筌 @kevinkaichuang.bsky.social · 21/02/2025
All-atom fixed backbone protein sequence design with FAMPNN @richardshuai.bsky.social Talal Widatalla @possuhuanglab.bsky.social @brianhie.bsky.social www.biorxiv.org/content/10.1...
FAMPNN architecture
0307
Reposted by Leo Scheller
cryoEM papers @cryoempapers.bsky.social · 21/02/2025
De novo design of transmembrane fluorescence-activating proteins pubmed.ncbi.nlm.nih.gov/39972138/ #cryoEM
031